These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 28971737)

  • 1. Translation and cultural adaptation of the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) pain scale into Arabic for use with patients with diabetes in Libya.
    Garoushi S; Johnson MI; Tashani OA
    Libyan J Med; 2017 Dec; 12(1):1384288. PubMed ID: 28971737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Translation and linguistic validation of the self-completed Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) scale for use in a Libyan population.
    Elzahaf RA; Tashani OA; Unsworth BA; Johnson MI
    Pain Pract; 2013 Mar; 13(3):198-205. PubMed ID: 22726274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translation, Cultural Adaptation, and Validation of Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) and Self-Complete Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) Questionnaires into the Greek Language.
    Batistaki C; Lyrakos G; Drachtidi K; Stamatiou G; Kitsou MC; Kostopanagiotou G
    Pain Pract; 2016 Jun; 16(5):552-64. PubMed ID: 25880345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validity and reliability of the Turkish Self-administered Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) questionnaire.
    Koc R; Erdemoglu AK
    Pain Med; 2010 Jul; 11(7):1107-14. PubMed ID: 20456071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross Cultural Adaptation and Validation of Italian Version of the Leeds Assessment of Neuropathic Symptoms and Signs Scale and Pain DETECT Questionnaire for the Distinction between Nociceptive and Neuropathic Pain.
    Migliore A; Gigliucci G; Moretti A; Pietrella A; Peresson M; Atzeni F; Sarzi-Puttini P; Bazzichi L; Liguori S; Iolascon G
    Pain Res Manag; 2021; 2021():6623651. PubMed ID: 34012496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-Cultural Psychometric Assessment of the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) Pain Scale in the Portuguese Population.
    Barbosa M; Bennett MI; Verissimo R; Carvalho D
    Pain Pract; 2014 Sep; 14(7):620-4. PubMed ID: 24289475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validity and reliability of the Spanish-language version of the self-administered Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) pain scale.
    López-de-Uralde-Villanueva I; Gil-Martínez A; Candelas-Fernández P; de Andrés-Ares J; Beltrán-Alacreu H; La Touche R
    Neurologia (Engl Ed); 2018 Oct; 33(8):505-514. PubMed ID: 27939112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cross-sectional study to estimate the point prevalence of painful diabetic neuropathy in Eastern Libya.
    Garoushi S; Johnson MI; Tashani OA
    BMC Public Health; 2019 Jan; 19(1):78. PubMed ID: 30654784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) questionnaire and its correlation with visual analog pain scales in Greek population.
    Spanos K; Lachanas VA; Chan P; Bargiota A; Giannoukas AD
    J Diabetes Complications; 2015; 29(8):1142-5. PubMed ID: 26345340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of Arabic version of the Neuropathic Pain Questionnaire-Short Form.
    Terkawi AS; Backonja MM; Abolkhair A; Almaharbi S; Joy J; Foula F; Alswiti M; Terkawi YS; Al-Zhahrani T; Alghamdi FS; Tsang S
    Saudi J Anaesth; 2017 May; 11(Suppl 1):S53-S62. PubMed ID: 28616004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brazilian Portuguese validation of the Leeds Assessment of Neuropathic Symptoms and Signs for patients with chronic pain.
    Schestatsky P; Félix-Torres V; Chaves ML; Câmara-Ehlers B; Mucenic T; Caumo W; Nascimento O; Bennett MI
    Pain Med; 2011 Oct; 12(10):1544-50. PubMed ID: 21883875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropathic Pain Questionnaire and Neuropathic Pain Questionnaire-Short Form: Translation, Reliability, and Validation Study of the Turkish Version.
    Yurdakul OV; Rezvani A; Kucukakkas O; Tolu S; Kilicoglu MS; Aydin T
    Turk Neurosurg; 2019; 29(5):683-688. PubMed ID: 31192441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Leeds Assessment of Neuropathic Symptoms and Signs Scale (LANSS) is not an adequate outcome measure of pressure ulcer-related neuropathic pain.
    Rutherford C; Nixon JE; Brown JM; Briggs M; Horton M
    Eur J Pain; 2016 Nov; 20(10):1710-1720. PubMed ID: 27172978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-cultural Adaptation and Linguistic Validation of the Korean Version of the Leeds Assessment of Neuropathic Symptoms and Signs Pain Scale.
    Park C; Lee YW; Yoon DM; Kim DW; Nam DJ; Kim DH
    J Korean Med Sci; 2015 Sep; 30(9):1334-9. PubMed ID: 26339176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of self report version of the Leeds Assessment of Neuropathic Symptoms and Signs score for identification of neuropathic pain in patients from northern Turkey.
    Türkel Y; Türker H; Demir IA; Bayrak AO; Onar MK
    Adv Clin Exp Med; 2014; 23(4):599-603. PubMed ID: 25166445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linguistic adaptation, validation and comparison of 3 routinely used neuropathic pain questionnaires.
    Li J; Feng Y; Han J; Fan B; Wu D; Zhang D; Du D; Li H; Lim J; Wang J; Jin Y; Fu Z
    Pain Physician; 2012; 15(2):179-86. PubMed ID: 22430656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The S-LANSS score for identifying pain of predominantly neuropathic origin: validation for use in clinical and postal research.
    Bennett MI; Smith BH; Torrance N; Potter J
    J Pain; 2005 Mar; 6(3):149-58. PubMed ID: 15772908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Linguistic adaptation and Spanish validation of the LANSS (Leeds Assessment of Neuropathic Symptoms and Signs) scale for the diagnosis of neuropathic pain].
    Pérez C; Gálvez R; Insausti J; Bennett M; Ruiz M; Rejas J;
    Med Clin (Barc); 2006 Oct; 127(13):485-91. PubMed ID: 17043002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of Arabic version of the douleur neuropathique 4 questionnaire.
    Terkawi AS; Abolkhair A; Didier B; Alzhahrani T; Alsohaibani M; Terkawi YS; Almoqbali Y; Tolba YY; Pangililan E; Foula F; Tsang S
    Saudi J Anaesth; 2017 May; 11(Suppl 1):S31-S39. PubMed ID: 28616002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Painful Diabetic Neuropathy Using the Self-Completed Leeds Assessment of Neuropathic Symptoms and Signs Questionnaire in a Population with Diabetes.
    Aslam A; Singh J; Rajbhandari S
    Can J Diabetes; 2015 Aug; 39(4):285-95. PubMed ID: 25935401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.